Colitis, Ulcerative

• 

  Subject Areas on Research

  • A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features. 
  • A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. 
  • A review of rectal biopsy. 
  • A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach. 
  • A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation. 
  • Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. 
  • Adrenoleukodystrophy associated with vitiligo and ulcerative colitis. 
  • Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. 
  • Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. 
  • As Infliximab Use for Ulcerative Colitis Has Increased, so Has the Rate of Surgical Resection. 
  • Asymptomatic transient uveitis in children with inflammatory bowel disease. 
  • Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. 
  • Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. 
  • Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. 
  • Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. 
  • Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. 
  • Crohn's disease IRGM risk alleles are associated with altered gene expression in human tissues. 
  • Current management of pediatric inflammatory bowel disease. 
  • Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis. 
  • Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis. 
  • Defining the relationship between depression and disease activity in IBD using clinical disease activity indices: merit or misnomer? 
  • Development of IgA and IgG2 subclass deficiency after sulfasalazine therapy. 
  • Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. 
  • Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? 
  • Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. 
  • Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. 
  • Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. 
  • Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience. 
  • Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis. 
  • Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis. 
  • Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials. 
  • Emerging treatments for ulcerative colitis: a systematic review. 
  • Functional bowel symptoms in quiescent inflammatory bowel disease: more than just irritable bowel syndrome? 
  • Gastrointestinal dysfunction in the critically ill: nutritional implications. 
  • Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. 
  • Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. 
  • Guidelines for immunizations in patients with inflammatory bowel disease. 
  • Health-related quality of life after ileoanal pull-through evaluation and assessment of new health status measures. 
  • Hemolytic anemia in patients receiving sulfasalazine. 
  • Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. 
  • Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease. 
  • Ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: historical development and current status. 
  • Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. 
  • Immunosuppressive/Autoimmune Disorders. 
  • Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease. 
  • Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. 
  • Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. 
  • Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. 
  • Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates. 
  • Intra-abdominal venous thrombosis after colectomy in pediatric patients with chronic ulcerative colitis: incidence, treatment, and outcomes. 
  • Intraoperative disseminated intravascular coagulation in a patient with ulcerative colitis. 
  • Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis? 
  • Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated? 
  • Isolated cortical venous thrombosis and ulcerative colitis. 
  • John M. Kinney International Award for General Nutrition. Glutamine, heat shock protein, and inflammation--opportunity from the midst of difficulty. 
  • Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care. 
  • Letter: is there a bi-directional relationship between depression and IBD? 
  • Letter: smoking as a modifiable risk factor for a complicated course in Crohn's disease. 
  • Long-Term Outcomes in Indeterminate Colitis Patients Undergoing Ileal Pouch-Anal Anastomosis: Function, Quality of Life, and Complications. 
  • Long-term efficacy and safety of azathioprine in ulcerative colitis. 
  • Mycophenolate mofetil therapy for refractory inflammatory bowel disease. 
  • Nicotine as a therapeutic drug. 
  • Ocular Surface Epithelial Atypia Mimicking Squamous Neoplasia in Association With Ulcerative Colitis. 
  • Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. 
  • Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis. 
  • Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation? 
  • Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. 
  • Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. 
  • Patient preferences for surgical versus medical therapy for ulcerative colitis. 
  • Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis. 
  • Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. 
  • Pneumorrhachis, subcutaneous emphysema, pneumomediastinum, pneumopericardium, and pneumoretroperitoneum after proctocolectomy for ulcerative colitis: report of a case. 
  • Poor Correlation Between Patient-reported and Endoscopic Components of the Mayo Score in Ulcerative Colitis. 
  • Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem. 
  • Predictors of Outcome in Ulcerative Colitis. 
  • Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. 
  • Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. 
  • Pyoderma gangrenosum: a reappraisal of associated systemic diseases. 
  • Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis. 
  • Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy. 
  • Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. 
  • Reporting of relapse rates in a trial of mesalazine for ulcerative colitis. 
  • Richter's syndrome mimicking chronic colitis. A patient with diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. 
  • Sex Differences in Treatment Strategies Among Patients With Ulcerative Colitis: A Retrospective Cohort Analysis of Privately Insured Patients. 
  • Short bowel syndrome after continence-preserving procedures. 
  • Simple Clinical Colitis Activity Index: Accurate Assessment of Inflammatory Burden or Reflection of Low Mood and Somatoform Behavior? 
  • Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. 
  • Superior mesenteric artery syndrome following ileo-anal pouch procedure. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease. 
  • Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. 
  • Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. 
  • Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis. 
  • Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. 
  • Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. 
  • Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis. 
  • Therapy of inflammatory bowel disease: what to expect in the next decade. 
  • Toxic colitis with megacolon in a patient with malrotation. 
  • Tumor necrosis factor alpha and colitis-associated colon cancer. 
  • Ulcerative colitis. 
  • VSL#3 and remission in active ulcerative colitis: larger studies required. 
  • Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis. 
  • Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats.